|
⚲
|
| Biopharma Cayman Partners LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001468203 |
| Sale | 2009-06-26 ($21.2 M Sold) |
| Fund | |
| Phone | 2128832296 |
| Address | 110 East 59th Street New York, 10022 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Pablo Legorreta | |
| Pedro Gonzalez de Cosio | |
| Benjamin Schliemann |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Fund EQ-THM, a series of Equidate Investments, LLC
✚
|
0.0 | |
|
Fund EQ-XRW, a series of Equidate Investments, LLC
✚
|
0.0 | |
|
FundersClub 2BZ LLC
✚
|
0.0 | |
|
FundersClub 2WD LLC
✚
|
0.0 | |
|
FundersClub 7B7 LLC
✚
|
0.0 | |
|
FundersClub 9AQ LLC
✚
|
0.0 | |
|
FundersClub 9KQ LLC
✚
|
0.0 | |
|
FundersClub 9TA LLC
✚
|
0.0 | |
|
FundersClub DV2 LLC
✚
|
0.0 | |
|
Fund EQ-ONJ, a series of Equidate Investments LLC
✚
|
0.0 |